Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices. CanSino has established bacterial and cell/viral culture pilot facilities in compliance to the current GMP standard. We can provide service to our clients and partners for clinical trial material production.